Southeast Asian capital is circling ANZ wellness assets — and vice versa

For a decade the flow was ANZ brands chasing Southeast Asian consumers. In 2026 the capital began moving the other way: regional strategics and family offices in Singapore and Vietnam are buying into Australian wellness and healthcare platforms for their brand equity, IP and clinical credibility.

The logic is symmetric. ANZ founders want distribution into the region's demographics; SEA acquirers want a trusted brand and a compliance track record they can carry home. The corridor is where those two needs clear.

The best corridor deals are not exits — they are the founder trading a ceiling for a runway.

Singapore remains the capital hub and the natural holding jurisdiction; Vietnam is increasingly the origination market, where founder businesses are scaling fast and succession is arriving earlier than owners expect.

What it means

For sellers, this widens the buyer universe well beyond the obvious domestic names — often to the buyers willing to pay the most. For acquirers, it rewards those who can move with cultural fluency on both sides of the corridor.